- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Gleevec and CML
Total 473447 results
-
Augusta UniversityH. Jean Khoury Cure CML ConsortiumRecruitingLeukemia, Myeloid | Chronic Myeloid Leukemia, Chronic Phase | Adult CML | Leukemia,Myeloid, ChronicUnited States
-
Medical College of WisconsinH. Jean Khoury Cure CML ConsortiumRecruitingChronic Phase Chronic Myelogenous LeukemiaUnited States
-
Baylor College of MedicineRecruitingChronic Myeloid Leukemia | Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission | Chronic Myeloid Leukemia in RemissionUnited States
-
M.D. Anderson Cancer CenterRecruitingChronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsActive, not recruitingGIST and CMLChina, Finland, Turkey, Singapore, France, Switzerland, Thailand, Romania, Hong Kong, United Kingdom, United States
-
Bristol-Myers SquibbPPD; ICON Clinical Research; Q2 Solutions; Molecular MD; MultiPharma; Steering Committee and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaItaly, Thailand, United States, Belgium, Czechia, Hungary, Argentina, Austria, Brazil, Canada, China, France, Korea, Republic of, Poland, Spain
-
UNC Lineberger Comprehensive Cancer CenterCompletedChronic Myeloid Leukemia | Chronic Myeloid Leukemia, Chronic Phase | CML, Chronic Phase | CML - Philadelphia Chromosome | CML (Chronic Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompletedPolycythemia Vera | Chronic Myelomonocytic Leukemia | Hypereosinophilic Syndrome | Chronic Myeloid Leukemia | MastocytosisUnited States
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Philadelphia Positive Chronic Myeloid LeukemiaUnited States, Germany, United Kingdom, France, Italy
-
Novartis PharmaceuticalsCompletedHypereosinophilic Syndrome | Chronic Myelogenous Leukemia | Systemic Mastocytosis | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)United States, Poland, Italy, Belgium, Canada, France, Australia, Netherlands, Sweden, Switzerland, United Kingdom, Spain, Korea, Republic of, Austria, Germany, Denmark, Finland, Singapore, Taiwan, Hong Kong, New Zealand, Norway
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive CMLUnited States, Germany, Italy, France
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedAcute Myeloid Leukemia | Chronic Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Astex Pharmaceuticals, Inc.Eisai Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
University of Milano BicoccaCompletedChronic Myeloid LeukemiaCanada, Germany, Israel, Italy, Spain
-
Novartis PharmaceuticalsCompleted
-
PfizerWyeth is now a wholly owned subsidiary of PfizerCompletedChronic Myeloid LeukemiaFrance, United States, Spain, Belgium, Singapore, Poland, Canada, Japan, United Kingdom, Taiwan, Hungary, Germany, Argentina, Russian Federation, Turkey, Colombia, Italy, South Africa, Brazil, Chile, China, Hong Kong, India, Korea, Republic... and more
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelogenous Leukemia, Chronic, Chronic PhaseUnited States
-
Rex Cancer Center, Raleigh, NCNorthwestern UniversityTerminatedChronic Phase CMLUnited States
-
Newcastle UniversityBristol-Myers Squibb; Institute of Cancer Research, United Kingdom; Newcastle-upon-Tyne... and other collaboratorsCompletedMyeloid Leukemia, Chronic, Chronic PhaseUnited Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedAccelerated Phase Chronic Myelogenous Leukemia | Adult Acute Lymphoblastic Leukemia in Remission | Childhood Acute Lymphoblastic Leukemia in Remission | Childhood Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent... and other conditionsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Myelomonocytic Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Brigham and Women's HospitalCompletedMyelofibrosis | Chronic Myelomonocytic Leukemia | Myeloid Metaplasia | Agnogenic Myeloid MetaplasiaUnited States
-
Novartis PharmaceuticalsCompletedCHRONIC MYELOGENOUS LEUKEMIACanada, Australia, Spain, Argentina, France, Brazil
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterNovartisCompletedLeukemia, Myeloid, ChronicUnited States
-
Il-Yang Pharm. Co., Ltd.CompletedBone Marrow Diseases | Hematologic Diseases | Leukemia | Leukemia, Myeloid | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Philadelphia ChromosomeKorea, Republic of, Indonesia, Thailand, Philippines
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompleted
-
King Faisal Specialist Hospital & Research CenterCompleted
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaChina, Argentina, Russian Federation, Germany, Guatemala, Panama, Colombia, Mexico, Brazil, India, Poland, Venezuela
-
University of Massachusetts, WorcesterTerminatedChronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedAll Indications for Glivec/Gleevec and TasignaUnited States
-
ChemGenex PharmaceuticalsTerminatedMyeloid Leukemia, Chronic, Chronic-Phase | Myeloid Leukemia, Chronic | Myeloid Leukemia, Chronic, Accelerated-Phase | Blast PhaseUnited States
-
BayerCompletedChronic Myelogenous LeukemiaUnited States, France
-
Ariad PharmaceuticalsTerminatedChronic Myeloid LeukemiaUnited States, Australia, Austria, Belgium, Canada, Czech Republic, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Singapore, Slovakia, Spain, Sweden, Switz... and more
-
M.D. Anderson Cancer CenterAbiogen PharmaTerminatedChronic Myelogenous LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompleted
-
Seoul St. Mary's HospitalNovartisUnknownChronic Myeloid LeukemiaKorea, Republic of
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaCanada, Italy, United States, United Kingdom, Belgium, Germany, France, Switzerland, Austria, Denmark, Spain, Norway, Sweden, Netherlands, New Zealand, Australia
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
Novartis PharmaceuticalsTerminatedChronic Myeloid Leukemia (CML) | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) | Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN)Russian Federation
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, Chronic PhaseUnited States, Argentina, Italy, Canada, Australia, Brazil
-
M.D. Anderson Cancer CenterNovartisCompletedAcute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Agnogenic Myeloid MetaplasiaUnited States
-
Novartis PharmaceuticalsTerminatedMyelogenous LeukemiaUnited States, Germany, Belgium, Italy, Spain, Korea, Republic of, Brazil, Japan, Australia, Czech Republic
-
M.D. Anderson Cancer CenterCompletedChronic Myelogenous LeukemiaUnited States
-
New Mexico Cancer Care AllianceWithdrawnChronic Myelogenous LeukemiaUnited States
-
New Mexico Cancer Care AllianceCompletedCancer | Leukemia, OtherUnited States
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaUnited States
-
Astex Pharmaceuticals, Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
University of CincinnatiNovartisWithdrawnA Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid LeukemiaAcute Myeloid Leukemia | Chronic Myeloid Leukemia, Blast CrisisUnited States